March 14, 2025

Hepatic stellate cells control liver function and regeneration

Hepatic stellate cells control liver function and regeneration

Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers from the German Cancer Research Center (DKFZ), the Mannheim Medical Faculty and Columbia University in New York have now published in the journal Nature that hepatic stellate cells control liver metabolism as well as liver regeneration and size. The results of the study could contribute to new therapeutic approaches for liver diseases.

Hepatic stellate cells control the function of the liver. The different colors show specialized functions of the liver cells within the pentagonal to octagonal liver lobules. Source: Augustin/DKFZ

The liver is a central organ for carbohydrate and protein metabolism as well as for the detoxification of endogenous and exogenous substances. Its vital functions require a high regenerative capacity. Liver cells, so-called hepatocytes, make up about 60 percent of the total cell number of the organ. They have important metabolic tasks and are active in detoxification and metabolism. Endothelial cells provide mass transfer, cholangiocytes transport bile, and Kupffer cells act as a protective barrier.

Hepatic stellate cells are located along the specialized blood capillaries of the liver, known as sinusoids. They are known to drive liver fibrosis, but their actual physiological functions and interactions with other cells are largely uninvestigated.

Scientists led by Hellmut Augustin, DKFZ and the Mannheim Medical Faculty of Heidelberg University, and Robert F. Schwabe, Columbia University, New York, have now shown that stellate cells are essential for liver regeneration and liver metabolism.

Using a genetic trick, the teams led by the two senior authors bred mice whose livers contained no stellate cells. This affected the organ’s detoxification function and its ability to regenerate after injury. The finely balanced architecture of the liver lobules, in which the hepatocytes are arranged according to their different metabolic tasks, was completely disrupted without stellate cells.

The protein Rspondin 3 (RSPO3), which is preferentially produced in stellate cells and regulates the important WNT signaling pathway in liver cells, proved to be a key player in this process. When the researchers specifically switched off RSPO3 in stellate cells, this genetic manipulation had the same effects as the loss of stellate cells.

“The results show that hepatic stellate cells are not only involved in pathological processes, but also play an active role in protecting and regulating liver function,” explains Hellmut Augustin. ”It is particularly noteworthy that the selective silencing of Rspondin 3 leads to similar effects as the removal of the stellate cells themselves – with serious consequences for liver health.”

The researchers also showed that low RSPO3 levels are associated with unfavorable disease progression in patients with alcohol-associated and metabolic liver disease. The new results provide a potential approach for future therapeutic strategies. Instead of focusing solely on inhibiting stellate cells to prevent the development of fibrosis, future treatments could specifically maintain and support their positive, protective functions.

Publication:
Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, Qiuyan Sun,,Chuan Yin, Ki Hong Lee, Yana Geng, Presha Rajbhandari, Celine Hernandez, Marcella Steffani, Jingran Qie, Thomas Savage, Dhruv M. Goyal, Kevin C. Ray, Taruna V. Neelakantan, Deqi Yin, Johannes Melms, Brandon M. Lehrich, Tyler M. Yasaka, Silvia Liu, Michael Oertel, Tian Lan, Adrien Guillot, Moritz Peiseler, Aveline Filliol, Hiroaki Kanzaki, Naoto Fujiwara, Samhita Ravi, Benjamin Izar, Mario Brosch, Jochen Hampe, Helen Remotti, Josepmaria Argemi, Zhaoli Sun, Timothy J. Kendall Yujin Hoshida, Frank Tacke, Jonathan A. Fallowfield, Storm K. Blockley-Powell,Rebecca A. Haeusler, Jonathan B. Steinman, Utpal B. Pajvani, Satdarshan P. Monga,Ramon Bataller, Mojgan Masoodi, Nicholas Arpaia, Youngmin A. Lee, Brent R. Stockwell, Hellmut G. Augustin & Robert F. Schwabe: Hepatic stellate cells control liver zonation, size and functions via Rspondin 3.
Nature 2025, DOI: https://www.nature.com/articles/s41586-025-08677-w 

A picture is available for download:
PM_Augustin_Nature.jpg

Caption: Hepatic stellate cells control the function of the liver. The different colors show specialized functions of the liver cells within the pentagonal to octagonal liver lobules.

Note on use of images related to press releases 
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: “Source: Augustin/DKFZ”.
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ’s Press Office (phone: ++49-(0)6221 42 2854, E-mail). Any commercial use is prohibited.

Our latest News

discover more
The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

From AI-assisted brain tumor diagnostics to training a new generation of interdisciplinary specialists: Two European collaborative projects are set to advance the diagnostics of tomorrow. They are being coordinated by Professor Dr. Dr. Felix Sahm of the Heidelberg Medical Faculty at Heidelberg University and the Department of Neuropathology at Heidelberg University Hospital. The European Union […]

Two ERC Starting Grants for Scientists at Universität Heidelberg

Two ERC Starting Grants for Scientists at Universität Heidelberg

European Research Council funds groundbreaking projects in paleoclimatology and cancer neuroscience The European Research Council (ERC) is awarding two valuable grants for early career researchers – two ERC Starting Grants – to Heidelberg University. One of them, worth 1.5 million euros, goes to PD Dr. Sophie Warken, who does her research at the Institutes of […]

Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

With RACOON-LCS, PENGUIN and CanTEN, Heidelberg University’s Faculty of Medicine is leading projects on lung cancer screening, penicillin allergy and fungal infections within the Network of University Medicine (NUM), together with one other coordinating university for each project. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University are jointly leading three newly launched nationwide […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp